09:00 Unraveling the complexity of multivalvular heart diseases: challenges & solutions
Chairs: Philippe Unger, Mani Vannan

08:45 Case-based presentation. David Vancraeynest | See presentation
08:55 Understanding the hemodynamic interplay. Alison Duncan | See presentation
09:05 Risk stratification & decision-making. Nina Ajmone | See presentation
09:15 Surgical vs. transcatheter approaches. Joelle Kefer | See presentation

 09:40 Game-changers in valvular heart disease
Chairs: Erwan Donal, Gilbert Habib

09:40 Phenotyping & staging valvular heart disease. Mani Vannan | See presentation

 10:35 Jekyll & Hyde session: the best approach for asymptomatic aortic stenosis
Chairs: Kalil Fattouch, Konstantinos Papadopoulos, Alessandro Parolari
See presentation of the TAVI Session

10:35 Conservative management: a prudent approach? Philippe Pibarot
10:55 Early intervention: acting before it’s too late. Philippe Pibarot

 11:15 Prism vision: the best approach for “at risk” moderate aortic stenosis
Chairs: Gilbert Habib, Patrizio Lancellotti, Giovanni La Canna

11:15 Conservative management: a prudent approach? Augustin Coisne | See presentation
11:30 Early intervention: acting before it’s too late. Corrado Tamburino | See presentation

 12:00 The forgotten valvular heart disease: rheumatic VHD
Chairs: Geu-Ru Hong, Jadranka Separovic

12:00 The global burden of rheumatic valve disease. Geu-Ru Hong | See presentation
12:15 Physiopathology of rheumatic heart disease. Romain Capoulade | See presentation
12:30 Medical treatment and anticoagulation in rheumatic mitral stenosis. Claire Bouleti | See presentation
12:45 The place of percutaneous treatment in rheumatic disease. Alison Duncan | See presentation

 14:00 Cutting-edge insights in tricuspid regurgitation
Chairs: Bernard Cosyns, Gilles Dreyfus, Vincent Tchana-Sato

14:00 Risk scoring in tricuspid regurgitation: a game changer? Erwan Donal | See presentation
14:10 The right ventricle: does it really matter? Charlotte Lee Frost | See presentation
14:20 Isolated TR: when and how should we intervene? Matteo Pettinari | See presentation
14:30 Key lessons from randomized trials. Tadafumi Sugimoto | See presentation

 15:00 Valvular heart disease in high-risk situations
Chairs: Erwan Donal, Carla Sousa, Simona Sperlongano

15:00 Pregnancy & VHD: maternal & fetal risks. Agnes Pasquet | See presentation
15:10 VHD in non-cardiac surgery: perioperative strategies. Simona Sperlongano | See presentation
15:20 Active neoplasia & VHD: balancing cancer & cardiac care. Giuseppina Novo | See presentation
15:30 Athletes with VHD: sports eligibility & restrictions. Lieven Herbots | See presentation

More authorized presentations: